259 related articles for article (PubMed ID: 18054841)
1. Vaccination approaches to combat human metapneumovirus lower respiratory tract infections.
Herfst S; Fouchier RA
J Clin Virol; 2008 Jan; 41(1):49-52. PubMed ID: 18054841
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques.
Herfst S; Schrauwen EJ; de Graaf M; van Amerongen G; van den Hoogen BG; de Swart RL; Osterhaus AD; Fouchier RA
Vaccine; 2008 Aug; 26(33):4224-30. PubMed ID: 18585830
[TBL] [Abstract][Full Text] [Related]
3. Human metapneumovirus.
Deffrasnes C; Hamelin ME; Boivin G
Semin Respir Crit Care Med; 2007 Apr; 28(2):213-21. PubMed ID: 17458775
[TBL] [Abstract][Full Text] [Related]
4. New Approaches for Immunization and Therapy against Human Metapneumovirus.
Wen SC; Williams JV
Clin Vaccine Immunol; 2015 Aug; 22(8):858-66. PubMed ID: 26063237
[TBL] [Abstract][Full Text] [Related]
5. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR
J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769
[TBL] [Abstract][Full Text] [Related]
6. Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features.
Caracciolo S; Minini C; Colombrita D; Rossi D; Miglietti N; Vettore E; Caruso A; Fiorentini S
Pediatr Infect Dis J; 2008 May; 27(5):406-12. PubMed ID: 18382388
[TBL] [Abstract][Full Text] [Related]
7. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.
Cseke G; Wright DW; Tollefson SJ; Johnson JE; Crowe JE; Williams JV
J Virol; 2007 Jan; 81(2):698-707. PubMed ID: 17050599
[TBL] [Abstract][Full Text] [Related]
8. Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters.
Herfst S; de Graaf M; Schrauwen EJA; Sprong L; Hussain K; van den Hoogen BG; Osterhaus ADME; Fouchier RAM
J Gen Virol; 2008 Jul; 89(Pt 7):1553-1562. PubMed ID: 18559924
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate.
Biacchesi S; Skiadopoulos MH; Yang L; Lamirande EW; Tran KC; Murphy BR; Collins PL; Buchholz UJ
J Virol; 2004 Dec; 78(23):12877-87. PubMed ID: 15542640
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice.
Herd KA; Mahalingam S; Mackay IM; Nissen M; Sloots TP; Tindle RW
J Virol; 2006 Feb; 80(4):2034-44. PubMed ID: 16439559
[TBL] [Abstract][Full Text] [Related]
11. Live vaccines for human metapneumovirus designed by reverse genetics.
Buchholz UJ; Nagashima K; Murphy BR; Collins PL
Expert Rev Vaccines; 2006 Oct; 5(5):695-706. PubMed ID: 17181442
[TBL] [Abstract][Full Text] [Related]
12. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
13. Ten years of human metapneumovirus research.
Feuillet F; Lina B; Rosa-Calatrava M; Boivin G
J Clin Virol; 2012 Feb; 53(2):97-105. PubMed ID: 22074934
[TBL] [Abstract][Full Text] [Related]
14. [Human Metapneumovirus in hospitalized children - a review].
Wilkesmann A; Schildgen O; Eis-Hübinger AM; Lentze MJ; Bode U; Simon A
Klin Padiatr; 2007; 219(2):58-65. PubMed ID: 16586267
[TBL] [Abstract][Full Text] [Related]
15. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.
Zhang Y; Wei Y; Zhang X; Cai H; Niewiesk S; Li J
J Virol; 2014 Oct; 88(19):11411-29. PubMed ID: 25056882
[TBL] [Abstract][Full Text] [Related]
16. Current developments and prospects on human metapneumovirus vaccines.
Márquez-Escobar VA
Expert Rev Vaccines; 2017 May; 16(5):419-431. PubMed ID: 28116910
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis of human metapneumovirus infection and research on attenuated live vaccine].
Tang MZ; Dou Y; Zhao XD
Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):548-54. PubMed ID: 24857012
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model.
Hamelin ME; Gagnon C; Prince GA; Kiener P; Suzich J; Ulbrandt N; Boivin G
Antiviral Res; 2010 Oct; 88(1):31-7. PubMed ID: 20619294
[TBL] [Abstract][Full Text] [Related]
19. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity.
Buchholz UJ; Biacchesi S; Pham QN; Tran KC; Yang L; Luongo CL; Skiadopoulos MH; Murphy BR; Collins PL
J Virol; 2005 Jun; 79(11):6588-97. PubMed ID: 15890897
[TBL] [Abstract][Full Text] [Related]
20. Protection against avian metapneumovirus subtype C in turkeys immunized via the respiratory tract with inactivated virus.
Cha RM; Khatri M; Sharma JM
Vaccine; 2011 Jan; 29(3):459-65. PubMed ID: 21073989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
